MAP2K1 and infection: Importantly, the bacterial killing assay demonstrated that PD0325901 significantly reduced intracellular bacterial burden in BMDMs at indicated time points post-infection (Figs 3D and S2B), indicating enhanced bactericidal function of macrophages with MEK1/2 pathway inhibition.